- Home
- CSV vs RIGL Comparison
CSV vs RIGL Comparison
Compare CSV & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSV | RIGL |
|---|---|---|
| Founded | 1991 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 643.0M | 564.7M |
| IPO Year | 1996 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CSV | RIGL |
|---|---|---|
| Price | $40.74 | $36.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $59.00 | $45.67 |
| AVG Volume (30 Days) | 103.1K | ★ 313.1K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.92% | N/A |
| EPS Growth | 54.76 | ★ 1867.68 |
| EPS | ★ 0.84 | 0.44 |
| Revenue | ★ $417,440,000.00 | $294,282,000.00 |
| Revenue This Year | $7.35 | N/A |
| Revenue Next Year | $3.87 | $12.75 |
| P/E Ratio | ★ $48.06 | $83.66 |
| Revenue Growth | 3.28 | ★ 64.15 |
| 52 Week Low | $36.39 | $21.93 |
| 52 Week High | $52.10 | $52.24 |
Technical Indicators
Market Signals| Indicator | CSV | RIGL |
|---|---|---|
| Relative Strength Index (RSI) | 55.78 | 45.95 |
| Support Level | $36.88 | $33.93 |
| Resistance Level | $40.21 | $44.42 |
| Average True Range (ATR) | 1.22 | 1.68 |
| MACD | 0.37 | -0.58 |
| Stochastic Oscillator | 70.98 | 25.85 |
Price Performance
Historical ComparisonAbout CSV Carriage Services Inc.
Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise. The company enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.